Clinical Trials Directory

Trials / Completed

CompletedNCT04217668

Headache Provocation of People Who Are Unable to Have Headache

Pain Perception, Headache Provocation and Multiomics of People Who Are Unable to Have Headache

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
58 (actual)
Sponsor
Danish Headache Center · Academic / Other
Sex
Male
Age
18 Years – 70 Years
Healthy volunteers
Not accepted

Summary

Headaches are extremely common illnesses with a combined lifetime prevalence of 90-99% in Europe. Despite this high prevalence, there are persons who have never, in their whole life, encountered a headache. The aim of the study is to identify factors that protect against headache by studying headache after provocation in people who never have had a headache (headache resistant) versus non-resistant controls. The investigators will use isosorbide mononitrate as a pharmacological trigger of headache. The provocation is performed by investigators who are blinded to the grouping of the participants. The investigators hope to contribute with novelty to the current understanding of headache pathophysiology and development of more efficient treatment of headache.

Conditions

Interventions

TypeNameDescription
DRUGIsosorbide Mononitrate 60 MG1 tablet Isosorbide Mononitrate 60 mg administrated orally.

Timeline

Start date
2019-12-02
Primary completion
2020-03-12
Completion
2020-03-12
First posted
2020-01-03
Last updated
2021-03-25

Locations

1 site across 1 country: Denmark

Source: ClinicalTrials.gov record NCT04217668. Inclusion in this directory is not an endorsement.